Application Nr Approved Date Route Status External Links
NDA020397 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Zanaflex Is A Central Alpha-2-Adrenergic Agonist Indicated For The Management Of Spasticity. Because Of The Short Duration Of Therapeutic Effect, Treatment With Zanaflex Should Be Reserved For Those Daily Activities And Times When Relief Of Spasticity Is Most Important [ See Dosage And Administration(2.1) ]. Zanaflex Is A Central Alpha-2-Adrenergic Agonist Indicated For The Management Of Spasticity. Because Of The Short Duration Of Therapeutic Effect, Treatment With Zanaflex Should Be Reserved For Those Daily Activities And Times When Relief Of Spasticity Is Most Important. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Tizanidine Hydrochloride TIZANIDINE HYDROCHLORIDE ZINC19702309

Comments